AORT Artivion, Inc.
Artivion, Inc. (AORT) is expected to report earnings on November 5, 2026, after the market close. The consensus earnings estimate is $0.11 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +8.3% since its last earnings release on August 6, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases.
Sector
Healthcare
Industry
Medical Instruments/Supply